International Research Ethics: Issues in Prevention Trials Steve Morin, Ph.D. AIDS Policy Research Center AIDS Research Institute University of California,

Slides:



Advertisements
Similar presentations
Child Protection Units
Advertisements

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
State of Texas HIV Planning &. Goals for the National HIV/AIDS Strategy 1.Reduce new HIV infections 2.Increase access to care and improve health outcomes.
What You Will Learn From These Sessions
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Nationals HIV/AIDS Strategy and how the mission of Women Accepting Responsibility, Inc. is helping to meet this goal. By She’kell Hutchinson Program Director,
Interim Care Centers, The Role of Local Partners Jessica Izquierdo, MPH Technical Advisor, Youth Programs.
Subject Selection and Recruitment David Wendler Department of Clinical Bioethics NIH, USA.
New Employee Orientation
1 Ethical issues in international clinical trials Bernard Lo, M.D. University of California San Francisco May 28, 2009.
New Employee Orientation (Insert name) County Health Department.
Linda Chamberlain, PhD MPH IPV and Sexually Transmitted Infections/HIV MENU Overview Regional and Local Data The Impact of IPV on Women’s Health IPV and.
International Multi-Site and Multi-disciplinary Studies Thomas J. Coates PhD Director, UCLA Center for World Health Michael and Sue Steinberg Professor.
1 Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may be outdated.
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.
HIV Prevention Trials Network Update Africa Regional Working Group 20 May 2003.
Prevention with Positives; Using Multiple Strategies to Involve Persons Living with HIV in Prevention. TASO Uganda. Emmanuel Odeke,
Community Issues And Needs Associated With Microbicides Clinical Trials Presenter: John M. Mutsambi, Community Liaison Officer with University of Zimbabwe.
Science for Global Health: Fostering International Collaboration Norka Ruiz Bravo,PhD Special Advisor to the Director National Institutes of Health U.S.
Dorcas Sithole Mental Health Department Ministry of Health & Child Welfare 1.
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
HRSA’s Oral Health Goals and the Role of MCH Stephen R. Smith Senior Advisor to the Administrator Health Resources and Services Administration.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
Needs Assessment: Young People’s Drug and Alcohol Services in Edinburgh City EADP Children, Young People and Families Network Event 7 th March 2012 Joanne.
PRESENTATION TO PARLIAMENT Education Portfolio Committee 21 October 2008 Mr. Mahalingum Govender Principal Investigator Accounting Officer ELRC HIV/AIDS.
The NIDCR funded Collaborating Research Centers to Reduce Oral Health Disparities (CRCROHD) represent an innovative approach to understanding determinants.
Understanding TASC Marc Harrington, LPC, LCASI Case Developer Region 4 TASC Robin Cuellar, CCJP, CSAC Buncombe County.
1 Ethical issues in clinical trials Bernard Lo, M.D. February 10, 2010.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
COMMUNITY CONSULTATION: LESSONS LEARNED IN HIV COMMUNITY-BASED RESEARCH Ronald P. Strauss, D.M.D., Ph.D. University of North Carolina at Chapel Hill.
Scaling-up male circumcision programmes in the Eastern and Southern Africa Region Country update meeting HIV Testing and Counseling and Male Circumcision.
Overview of the CHAPPL Network, Zimbabwe ( Care for HIV/AIDS Prevention and Positive Living Network) Charity Alfredo (CDC) Vulyewa.
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
Principles and Practices: The implementation of ethical guidelines for research on HIV Geneva, 2-3 June 2003 Ethical guidelines for HIV vaccines: Generic.
The Feasibility of Community-Based VCT in Zimbabwe Gertrude Khumalo-Sakutukwa and Steve Morin AIDS Policy Research Center AIDS Research Institute University.
Report back from CWG Strategic Planning Strategic Planning Workshop February 2002 Janet Frohlich Steve Morin CWG International CWG US Co-Chair Co-chair.
Evaluation of the Indiana ECCS Initiative. State Context Previous Early Childhood System Initiatives –Step Ahead –Building Bright Beginnings SPRANS Grant.
Nash 1 “ Advancing Health Equity through State Implementation of Health Reform” Creshelle R. Nash, MD, MPH Assistant Professor, Department of Health Policy.
Ryan White All Grantees Meeting Washington, DC November, 2012 Supporting National HIV/AIDS Strategies: the domestic experience and the AETCs.
Community-Level HIV Incidence Outcomes of NIMH Project Accept (HPTN 043) Glenda Gray for the Project Accept Study Team IAS July 2013 Kuala Lumpur,
The Importance of a Strategic Plan to Eliminate Health Disparities 2008 eHealth Conference June 9, 2008 Yvonne T. Maddox, PhD Deputy Director Eunice Kennedy.
Covered California: Promoting Health Equity and Reducing Health Disparities Covered California Board Meeting March 21, 2013.
Quality of Voluntary Medical Male Circumcision Services during Scale-Up: A Comparative Process Evaluation in Kenya, South Africa, Tanzania and Zimbabwe.
Ensuring Adherence and Retention to HIV Care and Treatment among Orphans and Vulnerable Children A Multi-Country Experience Thebisa Chaava MPH Senior Technical.
Component 1: Introduction to Health Care and Public Health in the U.S. 1.1: Unit 2: Health Care Settings 1.2 a: Overview and the Organization of Federal.
HIV AND INFANT FEEDING A FRAMEWORK FOR PRIORITY ACTIONS.
Thorny Issues in HIV Vaccine Trials Saul Walker Policy Advisor IAVI.
From the Report Building from Common Foundations: The World Health Organization and Faith-Based Organizations in Primary Health Care The Reverend Canon.
1 Executive Summary of the Strategic Plan and Proposed Action Steps January 2013 Healthy, Safe, Smart and Strong 1.
1/28/2016 Prevention Research and Natioanl Aids Plans Geneva 1 Prevention Research and National AIDS Plans June 2005 Geneva, Switzerland Prof. Roy.
California Department of Public Health Office of AIDS HIV CARE and PREVENTION 2009: You Need to Know.
De Beers Response to HIV/AIDS 19 th June 2006 World Bank Group- CommDev Workshop.
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
World Vision Experiences in Making ART Treatment Affordable and Available Dr. Daniel J Malleboyina M.B.B.S, MBA, MPH Regional Advisor HIV & AIDS- Asia.
Resource Review for Teaching Resource Review for Teaching Victoria M. Rizzo, LCSW-R, PhD Jessica Seidman, LMSW Columbia University School of Social Work.
Minnesota’s Promise World-Class Schools, World-Class State.
Workshop on Regional Cooperation on Animal Welfare Amman October 2009.
Science & Technology for National Progress in African Region: Highlights of Regional Strategy and Action Professor Gabriel B. Ogunmola, FAS President,
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
Prevention of Mother-to-Child Transmission of HIV: Scale-up of Critical Services in Uganda (District- based Approach) Edward Bitarakwate, MD, MPH Technical.
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
Community Participation in Research
NIMH Project Accept (HPTN 043) HIV/AIDS Community mobilization (CM) and Mobile HIV voluntary counseling and testing (MVCT) utilization in rural Thai.
Richard hayes London school of hygiene & Tropical Medicine
Building Public Health Nursing Capacity through Shared Services
A pathway to policy commitment for sustainability of a key population-led health services model in Thailand Dr. Preecha Prempree Deputy Director-General,
Presentation transcript:

International Research Ethics: Issues in Prevention Trials Steve Morin, Ph.D. AIDS Policy Research Center AIDS Research Institute University of California, San Francisco

NIH Funding for International AIDS Research, FY Source: Fauci, NIAID, 2003

The Community-Based VCT Prevention Trial F HPTN 043: A Phase IIB Randomized Trial to Evaluate the Efficacy of Community-Based HIV Voluntary Counseling and Testing to Reduce HIV Seroincidence (funded by NIMH). F 32 communities in Africa (Tanzania, Zimbabwe, and South Africa) and 14 communities in Thailand will be randomized to either a community-based HIV voluntary counseling and testing (CBVCT) intervention or clinic-based standard VCT (SVCT).

Background F Most HIV infections are in sub-Saharan Africa, yet only a small fraction of Africans know their HIV status. F Voluntary HIV Counseling and Testing (VCT) is an effective method of promoting behavior change, but utilization of VCT is still low in African communities with a high prevalence of HIV.

Zimbabwe Harare ~25% of sexually active Zimbabwean adults are infected with HIV, yet a small percentage know their HIV status

Community-Based VCT F Intervention has three major strategies: v to make VCT more available in community settings v to engage the community through outreach; and v to provide post-test support. F These three strategies are designed to change community norms and reduce risk for HIV infection among all community members, irrespective of whether they participated directly in the intervention.

The road to market in Epworth

Mobile VCT Pilot Study F Offered free, anonymous VCT from a mobile caravan F Rotated once a week to 6 sites in Epworth F Rapid tests were performed (15 minutes) F Testers were offered the option to wait for results outside the caravan or return on another day

“Plan for Tomorrow -- Get HIV Tested Today”

Setting up the caravan for VCT at the Solani Marketplace in Epworth

Counselors and outreach worker ready for action

What’s different about international research? F Vast disparities in wealth between sponsor and host countries F Limited resources in host country F History of exploitation

Anticipating Ethical Issues

What are the ethical issues? F Research questions and priorities F Interventions for control group F Post-trial access to interventions F Informed consent F IRB review

Research questions and priorities F Helsinki v“a reasonable likelihood that [study populations] stand to benefit from the results” F NBAC v“limited to those studies that are responsive to the health needs of the host country”

Response F The CBVCT question emerged from prior research in Tanzania and Kenya. F Issue is considered important to key stakeholders in revising the National AIDS Control Plan. F It addresses both an important behavioral science question and a need of the host country.

Interventions for control group F Helsinki v“Best current prophylactic, diagnostic, and therapeutic methods” vRejected “highest attainable and sustainable” standard F NBAC vEffective treatment preferred, but current (no) care may be justified to meet host country health needs

Response F The standard of care (SOC) for VCT as a prevention intervention was established in the Tanzania and Kenya trial. F In the control arm of this trial, we establish the same clinic-based VCT as SOC. F SOC was chosen over “available care” for scientific as well as ethical reasons.

Post-trial access to interventions F Helsinki vSubjects “should be assured of access to the best proven prophylactic, diagnostic, and therapeutic methods identified by the study F NBAC v“Reasonable, good faith efforts” to provide access to participants vAddress access issues in planning vNegotiate agreements in advance

Response F Representative from the Zimbabwe Ministry of Health National AIDS Control Program serves as an investigator. F USAID involved in planning and primary VCT contractor serves as technical advisor. F CDC involved in planning and developing laboratory measures for assessing primary endpoint.

Informed Consent F Communicate information von multiple levels (community, family, individual) vin multiple formats (oral, written) vover time F Assess participant’s understanding

Response F Involved local researchers in developing the informed consent documents. F Developed Community Advisory Board that reviewed consent documents and process. F Modified US approaches to be reduce miscommunication. F Integrated concepts of informed consent into pre-test counseling.

Where does HIV Prevention Research Fit in the Big Picture?

Coverage of Antiretroviral Therapy in Developing Countries, 2002 (Adults by Region) Source: Fauci, NIAID, 2003

Total Federal HIV/AIDS Spending by Category FY 2002 Source: Kaiser Family Foundation, 2003

Total Federal HIV/AIDS Spending by Department of Agency FY 2002 Source: Kaiser Family Foundation, 2003

The President’s Emergency Plan for AIDS Relief Source: Fauci, NIAID, 2003

The International Mother and Child Prevention Initiative Source: Fauci, NIAID, 2003

President’s Emergency Plan for AIDS Relief: Funding Breakdown Source: Fauci, NIAID, 2003

NIH Mission 1) Foster fundamental creative discoveries, innovative research strategies, and their applications as a basis to advance significantly the Nation’s capacity to protect and improve health; 2) Develop, maintain, and renew scientific human and physical resources that will assure the Nation’s capability to prevent disease; 3) Expand the knowledge base in medical and associated sciences in order to enhance the Nation’s economic well- being and ensure a continued high return on the public investment in research; and 4) Exemplify and promote the highest level of scientific integrity, public accountability, and social responsibility in the conduct of science.

Planning for Unanticipated Ethical Challenges

Community Advisory Boards F Represent community -- bridge, link, go-between, liaison -- make suggestions about protocols F Safeguard/protect the community -- clearinghouse for ethical issues -- promote respect for participants F Legitimize research in communities -- respond to misinformation, provide access

“That is why you saw us coming to look in, when the caravan came … people could see that I was also involved in this project and that they should not try anything because I am here and we are the ones who have brought this project. We were giving ourselves accolades...you thought you had the accolades but we were the ones who had them! We want to tell you … we were telling people we brought the project so that they could embrace it, there was no problem my children (referring to staff).” Barbara Mangwende, Chair of the Epworth CAB Community leaders play an important role, as they facilitate access to the local community, as well as understanding and acceptance of research.

Bread F Challenge: Many participants coming for pilot study were weak from hunger. Nurse raised issue of whether we can feed them bread? F Should the research study feed them?

Response F Extensive discussion in counseling supervision session and consultation with other projects. F Determined that offering food would be coercive under the circumstances; referral to food programs would be more appropriate. F Providing food (incentive) would also change the study -- would no longer be testing whether changing community norms leads to increased awareness of status and decreased new infections.

Antiretroviral Therapy F Challenge: HIV drugs are not generally available. Referral options are limited. Treatment advocates, some developing country researchers, and some at NIH have suggested it is “unethical” to conduct HIV testing if the researchers do not provide treatment. F What should the researchers do?

Response F Conducted focused discussion of the issue with local CAB. F Consensus was that VCT was of benefit to participants and community even in absence of treatment. F Providing treatment would also change the study - - would no longer be testing whether changing community norms leads to increased awareness of status and decreased new infections.

HPTN Guidance F Prevention trials should make “practically achievable” effective prevention methods “reasonably available” to all people screened or enrolled -- VCT & condom availability. F In conducting research in settings where standards of HIV care are poor, consider opportunities to contribute to the local infrastructure.

What should investigators do? F Raise and address issues vExpect close scrutiny and harsh criticism vJustify design proactively vPlan for potential criticisms F Make good-faith, reasonable efforts vInvolve host country scientists, community leaders, political leaders F Seek US and host country review and consider community consultation

Acknowledgements F National Institute of Mental Health (NIMH) and Office of AIDS Research (OAR) F Leslie Wolf, JD & Bernard Lo, MD, UCSF Program in Medical Ethics and CAPS Policy & Ethics Core F Epworth Community Advisory Board and Epworth Local Board F Community Working Group & Ethics Working Group, HIV Prevention Trials Network F Zimbabwe Investigators: Gertrude Khumalo- Sakutukwa, Katherine Fritz, Tinofa Mutevedzi, Taurai Vaki and Owen Mapfumo